Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Laboratory Corp of America Holdings (LH)

Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,433,344
  • Shares Outstanding, K 82,900
  • Annual Sales, $ 13,009 M
  • Annual Income, $ 746,000 K
  • EBIT $ 1,615 M
  • EBITDA $ 2,258 M
  • 60-Month Beta 1.03
  • Price/Sales 1.68
  • Price/Cash Flow 11.35
  • Price/Book 2.72

Options Overview Details

View History
  • Implied Volatility 23.89% (+0.57%)
  • Historical Volatility 24.66%
  • IV Percentile 65%
  • IV Rank 29.25%
  • IV High 41.59% on 04/10/25
  • IV Low 16.57% on 08/22/25
  • Expected Move (DTE 25) 2.42 (0.85%)
  • Put/Call Vol Ratio 0.23
  • Today's Volume 80
  • Volume Avg (30-Day) 192
  • Put/Call OI Ratio 0.65
  • Today's Open Interest 1,413
  • Open Int (30-Day) 4,283
  • Expected Range 282.88 to 287.72

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 4.09
  • Number of Estimates 8
  • High Estimate 4.21
  • Low Estimate 3.97
  • Prior Year 3.84
  • Growth Rate Est. (year over year) +6.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
260.57 +9.49%
on 02/17/26
292.02 -2.30%
on 02/12/26
+18.64 (+6.99%)
since 01/23/26
3-Month
245.00 +16.45%
on 01/05/26
292.02 -2.30%
on 02/12/26
+19.66 (+7.40%)
since 11/21/25
52-Week
209.38 +36.26%
on 04/21/25
293.72 -2.87%
on 10/21/25
+35.45 (+14.19%)
since 02/21/25

Most Recent Stories

More News
Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide

AISight® Dx will support fully digital workflows and AI-enabled insights across Labcorp's network of anatomic pathology labs and hospital collaborations to improve efficiency, collaboration and patient...

LH : 285.30 (+0.93%)
Labcorp Holdings Stock: Is Wall Street Bullish or Bearish?

Labcorp Holdings has outperformed the broader market over the past year, and analysts remain highly bullish about the stock’s prospects.

XLV : 158.54 (+1.10%)
$SPX : 6,837.75 (-1.04%)
LH : 285.30 (+0.93%)
LH Q4 Deep Dive: Specialty Testing and Hospital Partnerships Offset Volume Challenges

LH Q4 Deep Dive: Specialty Testing and Hospital Partnerships Offset Volume Challenges

LH : 285.30 (+0.93%)
Why Labcorp (LH) Shares Are Trading Lower Today

Why Labcorp (LH) Shares Are Trading Lower Today

LH : 285.30 (+0.93%)
Labcorp: Q4 Earnings Snapshot

Labcorp: Q4 Earnings Snapshot

LH : 285.30 (+0.93%)
Labcorp (NYSE:LH) Misses Q4 CY2025 Sales Expectations

Labcorp (NYSE:LH) Misses Q4 CY2025 Sales Expectations

LH : 285.30 (+0.93%)
Labcorp Announces 2025 Fourth Quarter and Full Year Results

Company Provides 2026 Guidance

LH : 285.30 (+0.93%)
Labcorp (LH) To Report Earnings Tomorrow: Here Is What To Expect

Labcorp (LH) To Report Earnings Tomorrow: Here Is What To Expect

LH : 285.30 (+0.93%)
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care

BURLINGTON, N.C. , Feb. 11, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide availability of the Elecsys®...

LH : 285.30 (+0.93%)
Labcorp Appoints John H. Sampson, M.D., Ph.D., to Board of Directors

BURLINGTON, N.C. , Feb. 9, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the appointment of John H. Sampson, M.D.,...

LH : 285.30 (+0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C.

See More

Key Turning Points

3rd Resistance Point 300.51
2nd Resistance Point 294.93
1st Resistance Point 290.12
Last Price 285.30
1st Support Level 279.73
2nd Support Level 274.15
3rd Support Level 269.34

See More

52-Week High 293.72
Last Price 285.30
Fibonacci 61.8% 261.50
Fibonacci 50% 251.55
Fibonacci 38.2% 241.59
52-Week Low 209.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar